Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-01

Clinical Trial Update: An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial of an implantable microneuromodulator for chronic shoulder pain in post-stroke patients has completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Implantable microneuromodulator

Snippet

Sponsor: Bioness Inc | Conditions: Shoulder Pain Chronic | Phase 2 | Status: COMPLETED | Results posted: 2016-04-01